COSMOS Pharmaceutical Corporation (JP:3349)
:3349
3349 Stock Chart & Stats
¥6699.00
¥109.00(1.60%)
At close: 4:00 PM EST
¥6699.00
¥109.00(1.60%)
Day’s Range― - ―
52-Week Range¥6,355.00 - ¥10,045.00
Previous CloseN/A
Volume659.40K
Average Volume (3M)399.89K
Market Cap
¥511.03B
Enterprise Value¥505.69B
Total Cash (Recent Filing)¥57.04B
Total Debt (Recent Filing)¥49.96B
Price to Earnings (P/E)22.8
Beta-0.23
Next Earnings
Apr 13, 2026EPS Estimate
100.69Next Dividend Ex-DateN/A
Dividend Yield0.93%
Share Statistics
EPS (TTM)81.73
Shares Outstanding80,001,600
10 Day Avg. Volume586,980
30 Day Avg. Volume399,893
Financial Highlights & Ratios
PEG Ratio0.85
Price to Book (P/B)2.72
Price to Sales (P/S)0.69
P/FCF Ratio-814.90
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)398.41
Revenue Forecast (FY)¥1.09T
Bulls Say, Bears Say
Bulls Say
Consistent Revenue GrowthSustained revenue growth demonstrates durable consumer demand and effective retail execution across the Cosmos store network. Over multiple years this trend supports scale advantages, predictable cash inflows for reinvestment in stores and merchandising, and a stronger competitive position in Japanese drugstore retail.
Solid Balance Sheet And ROELow leverage and a strong equity ratio provide financial flexibility to fund expansion, withstand retail cyclicality, and support supplier relationships. Robust ROE indicates management converts capital into returns efficiently, underpinning long-term shareholder value and capacity to finance strategic investments without excessive external funding.
Strong Operating Cash FlowHealthy operating cash flow signals the core retail business generates recurring cash from day-to-day operations, supporting working capital and store-level investment. This underlying cash generation is a durable strength that enables funding of inventories and operations even while free cash flow is impacted by capital spending.
Bears Say
Negative Free Cash Flow TrendA persistent negative free cash flow trend means reported earnings are not fully converting to discretionary cash, limiting the company’s ability to fund dividends, debt reduction, or expansion from internal resources. Over months this can pressure liquidity or force higher external financing for growth.
Rising Total DebtAn upward trend in total debt, even from a low base, reduces financial flexibility and increases exposure to interest costs. If debt growth outpaces cash generation, it can constrain strategic options, raise refinancing risk, and limit the company’s ability to react to industry changes or fund store investments sustainably.
Margin Pressure On EBITA declining EBIT margin signals rising cost pressure or mix shifts toward lower-margin categories. If sustained, margin erosion can reduce free cash flow and returns on invested capital, forcing tougher tradeoffs between price competitiveness, operating cost control, and investment in the store network.
COSMOS Pharmaceutical Corporation News
3349 FAQ
What was COSMOS Pharmaceutical Corporation’s price range in the past 12 months?
COSMOS Pharmaceutical Corporation lowest stock price was ¥6355.00 and its highest was ¥10045.00 in the past 12 months.
What is COSMOS Pharmaceutical Corporation’s market cap?
COSMOS Pharmaceutical Corporation’s market cap is ¥511.03B.
When is COSMOS Pharmaceutical Corporation’s upcoming earnings report date?
COSMOS Pharmaceutical Corporation’s upcoming earnings report date is Apr 13, 2026 which is tomorrow.
How were COSMOS Pharmaceutical Corporation’s earnings last quarter?
COSMOS Pharmaceutical Corporation released its earnings results on Jan 13, 2026. The company reported ¥81.73 earnings per share for the quarter, missing the consensus estimate of ¥84.01 by -¥2.28.
Is COSMOS Pharmaceutical Corporation overvalued?
According to Wall Street analysts COSMOS Pharmaceutical Corporation’s price is currently Overvalued.
Does COSMOS Pharmaceutical Corporation pay dividends?
COSMOS Pharmaceutical Corporation pays a Semiannually dividend of ¥37.5 which represents an annual dividend yield of 0.93%. See more information on COSMOS Pharmaceutical Corporation dividends here
What is COSMOS Pharmaceutical Corporation’s EPS estimate?
COSMOS Pharmaceutical Corporation’s EPS estimate is 100.69.
How many shares outstanding does COSMOS Pharmaceutical Corporation have?
COSMOS Pharmaceutical Corporation has 80,001,600 shares outstanding.
What happened to COSMOS Pharmaceutical Corporation’s price movement after its last earnings report?
COSMOS Pharmaceutical Corporation reported an EPS of ¥81.73 in its last earnings report, missing expectations of ¥84.01. Following the earnings report the stock price went down -3.795%.
Which hedge fund is a major shareholder of COSMOS Pharmaceutical Corporation?
Currently, no hedge funds are holding shares in JP:3349
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
COSMOS Pharmaceutical Corporation
COSMOS Pharmaceutical Corporation operates a chain of drug stores in Japan. It also operates 1,130 stores in the Kanto, Chubu, Kansai, Chugoku, Shikoku, and Kyushu regions. The company was founded in 1983 and is headquartered in Fukuoka, Japan.
Technical Analysis
Sundrug Co
―
Sugi Holdings Co
―
TSURUHA Holdings
―
Create SD Holdings Co., Ltd.
―
KUSURI NO AOKI HOLDINGS CO.,LTD.
―
Options Prices
Currently, No data available
---